Form 4 for EWTX Edgewise Therapeutics, Inc.
Accepted 2022-05-25 00:00:00 ET · period of report 2022-05-23 · accession 0001562180-22-004407 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-25 | 2022-05-23 | EWTX | Carruthers R Michael | CFO | M - OptEx | $0.71 | +9,000 | 12.0K | +300% | +$6,390 |
| D | 2022-05-25 | 2022-05-23 | EWTX | Carruthers R Michael | CFO | M - OptEx | $0.71 | -9,000 | 207.1K | -4% | -$6,390 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-23 | M | A | 9,000 | $0.71 | 12,000 | D | — | — | (F1) Includes 1,562 shares purchased on November 15, 2021 and 1,438 shares purchased on May 15, 2022 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-05-23 | M | D | 9,000 | $0.71 | 207,122 | D | $0.71 · — to 2030-09-01 | 9,000 Common Stock | (F2) 1/4th of the shares subject to the option became vested and exercisable on September 1, 2021 and 1/48th of the shares subject to the option continue to vest each month, subject to the Reporting Person continuing as a service provider through each vest date. |